Ravat F, Payre J, Peslages P, Fontaine M, Sens N. Burn: An inflammatory process. Pathol Biol (Paris). 2011;59(3):e63-e72.
Venet F, Tissot S, Debard A-L, et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med. 2007;35(8):1910-1917.
Fayazov AD, Shukurov SI, Shukurov BI, Sultanov BC, Namazov AN, Ruzimuratov DA. Disorders of the immune system in severely burned patients. Ann Burns Fire Disasters. 2009;22(3):121-130.
Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect. 2003;53(1):6-13.
Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect. 2009;10(5):389-397.
Marichy J, Banssillon V, Fabry J, Sepetjian M, Margue Y. Vital prognosis of burns. Anesth Analg (Paris). 1977;34(6):1293-1302.
De Pauw B, Walsh T, Donnelly J, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
Cornely OA, Bassetti M, Calandra T, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl 7):19-37.
Société française d’étude et de traitement des brûlures (SFETB). [Guidelines for use of antibiotics in burn patient at the acute phase–long text. Société française d’étude et de traitement des brûlures]. Ann Fr Anesth Reanim. 2009;28(3):265-274.
Millon L, Herbrecht R, Grenouillet F, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2016;22(9):810.e1-810.e8.
Legrand M, Gits-Muselli M, Boutin L, et al. Detection of circulating mucorales DNA in critically Ill burn patients: preliminary report of a screening strategy for early diagnosis and treatment. Clin Infect Dis. 2016;63(10):1312-1317.
Pedrosa AFB, Rodrigues AG. Candidemia in burn patients: figures and facts. J Trauma. 2011;70(2):498-506.
Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1:37.
Struck MF, Gille J. Fungal infections in burns: a comprehensive review. Ann Burns Fire Disasters. 2013;26(3):147-153.
Arnould J, Le Floch R. Infections fongiques des brûlé: revue. Ann Burns Fire Disasters. 2015;28(1):21-28.
Schaal JV, Leclerc T, Soler C, et al. Epidemiology of filamentous fungal infections in burned patients: A French retrospective study. Burns. 2015;41(4):853-863.
Becker WK, Cioffi WG, McManus AT, et al. Fungal burn wound infection. A 10-year experience. Arch Surg. 1991;126(1):44-48.
Sarabahi S, Tiwari VK, Arora S, Capoor MR, Pandey A. Changing pattern of fungal infection in burn patients. Burns. 2012;38(4):520-528.
Capoor MR, Sarabahi S, Tiwari VK, Narayanan RP. Fungal infections in burns: Diagnosis and management. Indian J Plast Surg. 2010;43(Suppl):S37-S42.
Mousa HA, Al-Bader SM, Hassan DA. Correlation between fungi isolated from burn wounds and burn care units. Burns. 1999;25(2):145-147.
Schofield CM, Murray CK, Horvath EE, et al. Correlation of culture with histopathology in fungal burn wound colonization and infection. Burns. 2007;33(3):341-346.
Horvath EE, Murray CK, Vaughan GM, et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg. 2007;245(6):978-985.
Mitchell TA, Hardin MO, Murray CK, et al. Mucormycosis attributed mortality: a seven-year review of surgical and medical management. Burns. 2014;40(8):1689-1695.
Cochran A, Morris SE, Edelman LS, Saffle JR. Systemic Candida infection in burn patients: a case-control study of management patterns and outcomes. Surg Infect. 2002;3(4):367-374.
Vinsonneau C, Benyamina M, Baixench MT, et al. Effects of candidaemia on outcome of burns. Burns. 2009;35(4):561-564.
Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37(9):1172-1177.
Ekenna O, Sherertz RJ, Bingham H. Natural history of bloodstream infections in a burn patient population: the importance of candidemia. Am J Infect Control. 1993;21(4):189-195.
Katz T, Wasiak J, Cleland H, Padiglione A. Incidence of non-candidal fungal infections in severe burn injury: an Australian perspective. Burns. 2014;40(5):881-886.
Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest. 2000;117(5):1434-1442.
Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45(4):321-346.
Walsh T, Anaissie E, Denning D, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(3):327-360.
Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48(12):1743-1751.
Millon L, Larosa F, Lepiller Q, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013;56(10):e95-e101.
